Physician
Obstetrics & Gynecology
Dr. Randall K. Gibb, MD
|
|
Give Review
Dr. Randall K. Gibb is an expert in the field of Obstetrics & Gynecology. He graduated from St Louis University School of Medicine. Randall Gibb is also published. He has 59 publications published. The lastest publication: "Endometrial stromal sarcoma involving the placenta.'
Publications
- We need a new paradigm in gynecologic Cancer care: SGO proposes solutions for delivery, quality and reimbursement policies.
- Ovarian Cancer patient surveillance after curative-intent initial treatment.
- The use of liquid-based cytology in Cervical cancer screening.
- The impact of liquid-based cytology in decreasing the incidence of Cervical cancer.
- ATR mutation in endometrioid endometrial Cancer is associated with poor clinical outcomes.
- Phase II evaluation of topotecan and navelbine in patients with recurrent ovarian, fallopian tube or primary peritoneal Cancer.
- CD83 gene polymorphisms increase susceptibility to human invasive Cervical cancer.
- Effect of a T0 radical hysterectomy specimen on survival for early stage Cervical cancer.
- Novel cytotoxic agents from an unexpected source: bile acids and Ovarian tumor apoptosis.
- Utility of parametrectomy for early stage Cervical cancer treated with radical hysterectomy.
- Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with Endometrial carcinomas of the endometrioid type.
- Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometrial Cancer.
- Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of Endometrial carcinoma.
- Colposcopic accuracy of obstetrics and gynecology residents.
- Bevacizumab combination therapy in heavily pretreated, recurrent Cervical cancer.
- CA-125 response in patients with recurrent ovarian or primary peritoneal Cancer treated with pegylated liposomal doxorubicin or topotecan.
- DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis.
- MLH3 mutation in endometrial Cancer.
- Long-term outcome of women who undergo panniculectomy at the time of gynecologic surgery.
- Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial Ovarian carcinoma: A retrospective analysis.
- Human papillomavirus triage for young women with atypical squamous cells of undetermined significance.
- Defective DNA mismatch repair and XRCC2 mutation in uterine carcinosarcomas.
- Preoperative lymph node staging of early-stage Cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography.
- Cervical sarcomas: an analysis of incidence and outcome.
- Resource utilization for ovarian Cancer patients at the end of life: how much is too much?
- Relationship of Ovarian neoplasms and body mass index.
- Human papillomavirus type and tobacco use as predictors of survival in early stage Cervical carcinoma.
- FDG-PET evaluation of Vaginal carcinoma.
- Cervical dysplasia in adolescents.
- Cervical carcinoma in the elderly: an analysis of patterns of care and outcome.
- Panniculectomy: improving lymph node yield in morbidly obese patients with Endometrial neoplasms.
- The role of topotecan for extending the platinum-free interval in recurrent ovarian Cancer: an in vitro model.
- Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history.
- Synchronous ovarian metastases at the time of laparotomy for colon Cancer.
- Increased risk for hereditary nonpolyposis colorectal Cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive ...
- Liquid-based cytology for the postirradiation surveillance of women with gynecologic malignancies.
- Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in Endometrial adenocarcinoma.
- Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial Cancers.
- The significance of pneumatosis intestinalis or bowel perforation in patients with gynecologic malignancies.
- Utility and cost-effectiveness of preoperative autologous blood donation in gynecologic and gynecologic oncology patients.
- Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar Cancer.
- No association between the c2 allele at the cytochrome P450IIE1 gene and alcohol induced liver disease, alcohol Korsakoff''s syndrome or alcohol dependence syndrome.
- Lymphokine-activated killer (LAK)-mediated lysis of sequentially isolated ovarian Cancer cell lines.
- Use of diphenylamine in the detection of apoptosis.
- Identification of a unique form of p53 in human cord blood associated with the development of maternal autoantibodies.
- Endometrial stromal sarcoma involving the placenta.
- Inhibition of endometrial Cancer cell lines by mifepristone (RU 486).
- Taxol-induced bcl-2 phosphorylation in ovarian Cancer cell monolayer and spheroids.
- Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian Cancer cell lines.
- Prognostic factors associated with response in platinum retreatment of platinum-resistant ovarian Cancer.
- A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian Cancer.
- Increased risk for abnormalities on perioperative colon screening in patients with microsatellite instability-positive Endometrial carcinoma.
- Phase II evaluation of a 3-day infusion of topotecan in patients with recurrent ovarian or primary peritoneal Cancer.
- Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial Cancer and concomitant atypical hyperplasia.
- Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus Cancer.
- Outcomes in 24 selected patients with stage IVB Cervical cancer and excellent performance status treated with radiotherapy and chemotherapy.
- Acute toxicity of postoperative IMRT and chemotherapy for endometrial Cancer.
- Bevacizumab therapy in patients with recurrent uterine neoplasms.
Schools
Loyola University Of ChicagoStritch School Of Medicine
Saint Louis University Hospital
University of Louisville School of Medicine
Procedures Preformed
- Pelvic Surgery
Conditions Treated
- Cervical Cancer
- Endometrial Cancer
- Ovarian Cancer
- Vaginal Cancer
- View All
Doctors Specialties
- Hematology
- Obstetrics
- Gynecology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access
- First Health (Coventry Health Care) PPO
- MultiPlan PPO
- Choice Plus POS
- Options PPO
Education
-
St Louis University School of Medicine -
Loyola University Chicago Stritch School of Medicine
Drug Facts
| NPI NUMBER | 1639195944 | |
| NPPES Provider LastName | GIBB | |
| NPPES Provider FirstName | RANDALL | |
| NPPES Provider ZIPCode | 591010905 | |
| NPPES Provider State | MT | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 126.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 10.32 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1639195944 |
| Last Name Of The Provider | GIBB |
| First Name Of The Provider | RANDALL |
| View All |
Similar Doctors
|
Dr. James M. Burke, MD |
|
Dr. Douglas T. Ezell, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin K. Lucas, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lisa R. Ross, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas Purcell, MD |
|
Dr. Maureen C. Lucas, MD
This Doctor is OpenDoctor Recommended.
|